Is a complete IBIO research report available?

No complete published report is available for iBio, Inc. (IBIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

iBio, Inc. (IBIO)

NASDAQ: IBIO · USD

$1.43

+0.03 (+2.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IBIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	71M
Revenue (ttm)	300K
Net income (ttm)	-27.6M
EPS (ttm)	-$0.39
Shares out	49.7M
Volume	1,213,322
Beta	1.27
Price target	$5.40	+277.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 300K
Net income (ttm): -27.6M
EPS (ttm): -$0.39
Market cap: 71M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IBIO indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001420720
Company name	iBio, Inc.
Country	United States
Country code	US
Cusip	451033708
Employees	20
Employees Change	4%
Employees Change Percent	25
Enterprise value	$-1.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4510337086
Last refreshed	2026-07-27
Market cap	$71M
Market cap category	Micro-Cap
Price	$1.43
Price currency	USD
Rev Per Employee	15,000x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	IBIO
Website	https://ibioinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-38.86%
FCF yield	-31.2%
P/B ratio	0.64x
P/S ratio	236.8x
PS Forward	1,065.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9,653%
EBITDA Margin	-9,298%
Gross margin	100%
Gross Profit	$300,000
Gross Profit Growth	-20%
Gross Profit Growth5 Y	-26.78%
Net Income	$-27.6M
Net Income Growth Years	2%
Pretax Margin	-9,202%
Profit Per Employee	$-1.4M
ROA	-34.5
Roa5y	-26.24
ROCE	-36.5
ROE	-62.09
Roe5y	-64.48
ROIC	-37.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-53.76%
Cagr15y	-45.52%
Cagr1y	88.07%
Cagr3y	-49.33%
Cagr5y	-70.46%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	-20x
Revenue Growth Years	1x
Revenue Growth5 Y	-36.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$85.8M
Cash	$74.8M
Current Assets	$77.3M
Current Liabilities	$6.5M
Debt	$2.3M
Debt Equity	$0.03
Equity	$77.5M
Interest Coverage	-202.5
Liabilities	$8.3M
Long Term Assets	$8.6M
Long Term Liabilities	$1.8M
Net Cash	$72.5M
Net Cash By Market Cap	$102
Net Cash Growth	11,241.47%
Net Debt Equity	$-0.93
Tangible Book Value	$75.7M
Tangible Book Value Per Share	$2.19
WACC	11.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.88
Net Working Capital	$-3.5M
Quick ratio	11.5
Working Capital	$70.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-688.29%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.96%
1Y total return	87.99%
200-day SMA	1.81
3Y total return	-87%
50-day SMA	1.63
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.77%
All Time High	30,300
All Time High Change	-100%
All Time High Date	2011-01-18
All Time Low	0.56
All Time Low Change	157.1%
All Time Low Date	2025-08-08
ATR	0.11
Beta	1.27
Beta1y	3.04
Beta2y	1.37
Ch YTD	-25.91
High	1.47
High52	3.82
High52 Date	2025-12-10
High52ch	-62.57%
Low	1.31
Low52	0.56
Low52 Date	2025-08-08
Low52ch	157.1%
Ma50ch	-12.43%
Price vs 200-day SMA	-20.91%
RSI	40.71
RSI Monthly	37.2
RSI Weekly	43
Sharpe ratio	1.05x
Sortino ratio	2.03
Total Return	-688.29%
Tr YTD	-25.91
Tr15y	-99.99%
Tr1m	-13.33%
Tr1w	3.62%
Tr3m	-20.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$5.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.06
Earnings Revenue Estimate	66,670x
Earnings Revenue Estimate Growth	-66.66x
Operating Income	$-29M
Operating margin	-9,653
Price target	$5.4
Price Target Change	$278
Price Target Change Top	$297

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,473,808%
Float Percent	91.54%
Net Borrowing	-957,000
Shares Insiders	1.71%
Shares Institutions	32%
Shares Out	49,678,561
Shares Qo Q	20.65%
Shares Yo Y	688.29%
Short Float	11.84%
Short Ratio	4.8
Short Shares	10.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-23.4M
Average Volume	1,069,687.6x
Bv Per Share	2.24
CAPEX	$-560,000
Ch10y	-99.96
Ch15y	-99.99
Ch1m	-13.33
Ch1w	3.62
Ch1y	87.99
Ch3m	-20.99
Ch3y	-87
Ch5y	-99.77
Ch6m	-36.44
Change	2.14%
Change From Open	2.14
Close	1.4
Days Gap	0
Depreciation Amortization	688,000
Dollar Volume	1,735,050.5
Earnings Date	2026-09-04
Earnings Time	bmo
EBIT	$-29M
EBITDA	$-27.9M
EPS	$-0.39
F Score	2
FCF	$-22.2M
FCF EV Yield	1,548.2x
FCF Per Share	$-0.45
Financing CF	91,824,000
Fiscal Year End	June
Founded	2,008
Investing CF	-27,542,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2023-11-29
Last Split Type	Reverse
Last10k Filing Date	2025-09-05
Ma150	1.98
Ma150ch	-27.67%
Ma20	1.52
Ma20ch	-5.86%
Net CF	42,677,000
Next Earnings Date	2026-09-04
Open	1.4
Optionable	No
Position In Range	77.42
Post Close	1.43
Postmarket Change Percent	1.4
Postmarket Price	$1.45
Ppne	5,076,000
Price Date	2026-07-24
Ptbv Ratio	0.94
Relative Volume	1.13x
Revenue	300,000x
SBC By Revenue	407.67x
Share Based Comp	1,223,000
Tr6m	-36.44%
Us State	California
Volume	1,213,322
Z Score	-3.6

iBio, Inc. (IBIO)

Coverage state: Market snapshot only — no published research

Generate the first IBIO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IBIO

Frequently asked questions